Cantor Fitzgerald Starts Solta Medical (SLTM) at Buy; Slimming the Waistline, Fattening the Top Line

Cantor Fitzgerald initiates coverage on Solta Medical (NASDAQ: SLTM) with a Buy. PT $4.00.

Analyst, Jeremy Feffer, said, "Aesthetic laser companies remain out of favor with investors despite the steady rebound in procedure volumes since the lows of late 2008/early 2009. Some companies are better positioned than others to differentiate themselves, and we believe that Solta falls into this category. The stock's multiple fails to account for the growth potential of the Liposonix opportunity and the strength of the base business, and we would be buyers at these levels."

For an analyst ratings summary and ratings history on Solta Medical click here. For more ratings news on Solta Medical click here.

Shares of Solta Medical closed at $3.02 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Cantor Fitzgerald Downgrades Better Home & Finance Holding (BETR) to Neutral
• Axis Capital Limited Assumes Jubilant Foodworks Ltd (JUBI:IN) at Reduce (3)
• Evercore ISI Starts Alvotech SA (ALVO) at Outperform